Literature DB >> 1382414

Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages.

M G O'Sullivan1, E M Huggins, E A Meade, D L DeWitt, C E McCall.   

Abstract

Prostaglandin H synthase is a key enzyme in the formation of prostaglandins and thromboxane from arachidonic acid. The recent cloning of a second prostaglandin H synthase gene, prostaglandin H synthase-2, which is distinct from the classic prostaglandin H synthase-1 gene, may dramatically alter our concept of how cells regulate prostanoid formation. We have recently shown that the enhanced production of prostanoids by lipopolysaccharide-primed alveolar macrophages involves the induction of a novel prostaglandin H synthase (J. Biol. Chem., (1992), 267, 14547-14550). We report here that the novel PGH synthase induced by lipopolysaccharide in alveolar macrophages is prostaglandin H synthase-2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382414     DOI: 10.1016/0006-291x(92)91313-f

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.

Authors:  V Puigneró; J Queralt
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

3.  Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells.

Authors:  D J Perkins; D A Kniss
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

4.  Attenuation of macrophage apoptosis by the cAMP-signaling system.

Authors:  A von Knethen; B Brüne
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans.

Authors:  A Tatsuguchi; C Sakamoto; K Wada; T Akamatsu; T Tsukui; K Miyake; S Futagami; T Kishida; Y Fukuda; N Yamanaka; M Kobayashi
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

6.  Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors.

Authors:  C J Grossman; J Wiseman; F S Lucas; M A Trevethick; P J Birch
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

7.  Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

Authors:  J Wilborn; L J Crofford; M D Burdick; S L Kunkel; R M Strieter; M Peters-Golden
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

Authors:  P Patrignani; G Santini; M R Panara; M G Sciulli; A Greco; M T Rotondo; M di Giamberardino; J Maclouf; G Ciabattoni; C Patrono
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction.

Authors:  Kimberly D P Hammer; Matthew L Hillwig; Jeffrey D Neighbors; Young-Je Sim; Marian L Kohut; David F Wiemer; Eve S Wurtele; Diane F Birt
Journal:  Phytochemistry       Date:  2008-08-15       Impact factor: 4.072

10.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

Authors:  B F McAdam; F Catella-Lawson; I A Mardini; S Kapoor; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.